| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |